These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26637290)

  • 1. GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus.
    Chung CP; Ormseth MJ; Connelly MA; Oeser A; Solus JF; Otvos JD; Raggi P; Stein CM
    Lupus; 2016 Mar; 25(3):296-300. PubMed ID: 26637290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free fatty acids are associated with metabolic syndrome and insulin resistance but not inflammation in systemic lupus erythematosus.
    Ormseth MJ; Swift LL; Fazio S; Linton MF; Raggi P; Solus JF; Oeser A; Bian A; Gebretsadik T; Shintani A; Stein CM
    Lupus; 2013 Jan; 22(1):26-33. PubMed ID: 23060481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis.
    Ormseth MJ; Chung CP; Oeser AM; Connelly MA; Sokka T; Raggi P; Solus JF; Otvos JD; Stein CM
    Arthritis Res Ther; 2015 May; 17(1):117. PubMed ID: 25956924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors.
    Asanuma Y; Chung CP; Oeser A; Shintani A; Stanley E; Raggi P; Stein CM
    J Rheumatol; 2006 Mar; 33(3):539-45. PubMed ID: 16463434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory mechanisms affecting the lipid profile in patients with systemic lupus erythematosus.
    Chung CP; Oeser A; Solus J; Avalos I; Gebretsadik T; Shintani A; Linton MF; Fazio S; Stein CM
    J Rheumatol; 2007 Sep; 34(9):1849-54. PubMed ID: 17659756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum leptin levels are associated with metabolic syndrome and carotid intima media thickness in premenopausal systemic lupus erythematosus patients without clinical atherosclerotic vascular events.
    Demir S; Erten G; Artım-Esen B; Şahinkaya Y; Pehlivan Ö; Alpay-Kanıtez N; Deniz G; Inanç M
    Lupus; 2018 Aug; 27(9):1509-1516. PubMed ID: 29954279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocan Levels and Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus.
    Icli A; Cure E; Cure MC; Uslu AU; Balta S; Mikhailidis DP; Ozturk C; Arslan S; Sakız D; Sahin M; Kucuk A
    Angiology; 2016 Sep; 67(8):749-55. PubMed ID: 26614790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Evaluation of Lipoprotein Variables in Systemic Lupus Erythematosus Reveals Adverse Changes with Disease Activity and Prednisone and More Favorable Profiles with Hydroxychloroquine Therapy.
    Durcan L; Winegar DA; Connelly MA; Otvos JD; Magder LS; Petri M
    J Rheumatol; 2016 Apr; 43(4):745-50. PubMed ID: 26834214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
    Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
    Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein subclasses and particle size determined by nuclear magnetic resonance spectroscopy in systemic lupus erythematosus.
    Chung CP; Oeser A; Raggi P; Solus JF; Avalos I; Linton MF; Fazio S; Stein CM
    Clin Rheumatol; 2008 Oct; 27(10):1227-33. PubMed ID: 18421545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum GlycA Level is Elevated in Active Systemic Lupus Erythematosus and Correlates to Disease Activity and Lupus Nephritis Severity.
    Dierckx T; Chiche L; Daniel L; Lauwerys B; Weyenbergh JV; Jourde-Chiche N
    J Clin Med; 2020 Mar; 9(4):. PubMed ID: 32244481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in the Inflammatory Marker GlycA over 13 Years in Young Adults Is Associated with Poorer Cognitive Function in Midlife.
    Cohen-Manheim I; Doniger GM; Sinnreich R; Simon ES; Pinchas-Mizrachi R; Otvos JD; Kark JD
    PLoS One; 2015; 10(9):e0138036. PubMed ID: 26406330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus.
    Rho YH; Chung CP; Oeser A; Solus J; Raggi P; Gebretsadik T; Shintani A; Stein CM
    J Rheumatol; 2008 Sep; 35(9):1789-94. PubMed ID: 18634156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.
    Rho YH; Solus J; Raggi P; Oeser A; Gebretsadik T; Shintani A; Stein CM
    Arthritis Care Res (Hoboken); 2011 Apr; 63(4):535-41. PubMed ID: 20890983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
    Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G
    PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus.
    Lertnawapan R; Bian A; Rho YH; Raggi P; Oeser A; Solus JF; Gebretsadik T; Shintani A; Stein CM
    Lupus; 2012 Mar; 21(3):279-87. PubMed ID: 22072023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis.
    Chung CP; Long AG; Solus JF; Rho YH; Oeser A; Raggi P; Stein CM
    Lupus; 2009 Aug; 18(9):799-806. PubMed ID: 19578104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Mok CC; Poon WL; Lai JP; Wong CK; Chiu SM; Wong CK; Lun SW; Ko GT; Lam CW; Lam CS
    Scand J Rheumatol; 2010; 39(1):42-9. PubMed ID: 20132070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of obesity on disease activity, damage accrual, inflammation markers and cardiovascular risk factors in systemic lupus erythematosus.
    Correa-Rodríguez M; Pocovi-Gerardino G; Callejas Rubio JL; Ríos Fernández R; Martín Amada M; Cruz Caparrós M; Ortego-Centeno N; Rueda-Medina B
    Panminerva Med; 2020 Jun; 62(2):75-82. PubMed ID: 32515571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.